Literature DB >> 11316177

Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis.

K Hanazaki1, S Kajikawa, N Koide, W Adachi, J Amano.   

Abstract

OBJECTIVES: Although the incidence of hepatocellular carcinoma (HCC) with hepatitis C virus (HCV) infection is higher than in patients with hepatitis B virus (HBV)-related HCC in Japan, the long-term prognosis and prognostic factors of HCV-related HCC after hepatic resection are poorly understood.
METHODS: The surgical outcome of HCV-related HCC in 172 consecutive patients who underwent hepatic resection between 1989 and 1997 was retrospectively clarified. Postresection prognostic factors were evaluated by univariate and multivariate analysis using Cox's proportional hazards model.
RESULTS: The overall incidence of postoperative complications was 23.2%, and 11 patients among that group had hospital deaths (6.4%) including 9 (5.2%) operative deaths. The mean and median overall survivals including hospital death after surgery were 41 months and 33 months, respectively. The 3-, 5-, and 7-yr overall survival rates after hepatic resection were 63%, 52%, and 47%, respectively. The 3-, 5-, and 7-yr disease-free survival rates after hepatic resection were 33%, 20%, and 15%, respectively. Multivariate analysis revealed that serum alpha-fetoprotein (AFP) of > or = 1000 ng/ml and the presence of vascular invasion were independent unfavorable prognostic factors affecting overall survival and that AFP of > or = 1000 ng/ml was an independently significant factor of poor disease-free survival.
CONCLUSIONS: We found the postresection survival of patients with HCV-related HCC should be stratified by the high value of AFP and the presence of vascular invasion. AFP may be the most powerful predictor of the long-term prognosis and recurrence in such patients.

Entities:  

Mesh:

Year:  2001        PMID: 11316177     DOI: 10.1111/j.1572-0241.2001.03634.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  29 in total

1.  Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

Authors:  A Grieco; M Pompili; G Caminiti; L Miele; M Covino; B Alfei; G L Rapaccini; G Gasbarrini
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  Clinicopathological characteristics of hepatitis B surface antigen-negative and hepatitis C antibody-negative hepatocellular carcinoma.

Authors:  Hiroya Iida; Tsukasa Aihara; Shinichi Ikuta; Naoki Yamanaka
Journal:  Oncol Lett       Date:  2015-08-04       Impact factor: 2.967

3.  Prognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue.

Authors:  Fuminori Sonohara; Yoshikuni Inokawa; Mitsuhiro Hishida; Mitsuro Kanda; Yoko Nishikawa; Suguru Yamada; Tsutomu Fujii; Hiroyuki Sugimoto; Yasuhiro Kodera; Shuji Nomoto
Journal:  Oncol Lett       Date:  2016-10-11       Impact factor: 2.967

4.  Concurrent and subsequent radiofrequency ablation combined with hepatectomy for hepatocellular carcinomas.

Authors:  Dongil Choi; Hyo K Lim; Hyunchul Rhim
Journal:  World J Gastrointest Surg       Date:  2010-04-27

5.  Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.

Authors:  Wen-He Zhao; Zhi-Min Ma; Xing-Ren Zhou; Yi-Zheng Feng; Bao-Shan Fang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

6.  Efficacy and safety of 6-month iron reduction therapy in patients with hepatitis C virus-related cirrhosis: a pilot study.

Authors:  Naoki Tanaka; Akira Horiuchi; Takahiro Yamaura; Michiharu Komatsu; Eiji Tanaka; Kendo Kiyosawa
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

7.  Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma.

Authors:  Bong-Wan Kim; Young-Bae Kim; Hee-Jung Wang; Myung-Wook Kim
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

8.  Diagnosis of hepatocellular carcinoma.

Authors:  Eldad S Bialecki; Adrian M Di Bisceglie
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

9.  Resection of peritoneal implantation of hepatocellular carcinoma after hepatic resection: risk factors and prognostic analysis.

Authors:  Chun-Nan Yeh; Miin-Fu Chen
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

10.  New indication for reduction surgery in patients with advanced hepatocellular carcinoma with major vascular involvement.

Authors:  Naoto Gotohda; Taira Kinoshita; Masaru Konishi; Toshio Nakagohri; Shinichiro Takahashi; Junji Furuse; Hiroshi Ishii; Masahiro Yoshino
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.